(Newsire,net — August 16, 2013) Oxford, PA — Dr. Malcolm H. Kelly, Optometrist at Oxford Family Eyecare located at 49South 2nd Street (across from the Oxford Library) announced today his decision to offer his patientsMacuHealth® with LMZ3 —a remarkable supplement prescribed for Age Related Macular Degeneration(AMD). AMD is the leading cause of late onset visual impairment and legal blindness in the Westernworld among people over the age of 50. The macula, which protects us from the sun’s harmful bluelight, is made up of three protective carotenoids; Lutein, Zeaxanthin, and Meso-zeaxanthin. Theseprotective carotenoids diminish as we age leaving the retina vulnerable to the damaging effects of bluelight which can lead to Age Related Macular Degeneration and, if left untreated, the eventual loss ofcentral vision.
“There is no cure for AMD, so early screening to determine which of my patients are at risk and regularmonitoring of high-risk patients is my focus. I accomplish this with the latest in screening technology,the Macular Densitometer. Screening facilitates early intervention with Macular Pigment ReplacementTherapy to possibly prevent the onset of Dry Age Related Macular Degeneration and slow down or stopthe progression in those already afflicted with the disease. MacuHealth is the supplement of choice inmy practice to help reduce risk and preserve vision.” said Dr. Kelly. “With later diagnosis, interventionfor AMD may be less effective so early screening is critical.”
About Macular Degeneration
AMD is a progressive disease associated with aging that causes damage to the macula, a small areaat the back of the eye. The central portion of the macula, called the fovea, is responsible for our sharpcentral vision allowing us to read, drive, watch television and perform other activities that requirefocused vision. Once significant central vision is lost, it cannot be restored and, if untreated, AMD canultimately lead to blindness. The disease usually begins in one’s forties or fifties but it might not resultin significant vision loss until one is in their sixties or seventies. Symptoms may not be noticeable untildamage has already occurred, thus the importance of early screening. Vision loss may occur slowly insome patients and rapidly in others – sometimes in a matter of weeks.
The Demographics of AMD
AMD is the leading cause of late onset visual impairment and legal blindness in the Western worldamong people over the age of 50. According to reports from the Macular Degeneration Association,AMD Alliance International and the Foundation for Fighting Blindness more people have AMD thanBreast Cancer, Prostate Cancer, Parkinson’s and Alzheimer’s disease combined. Over 15 millionpeople in North America are currently affected by AMD with 2.7 million new patients diagnosed everyyear. Experts estimate that, as the population ages, the number of those afflicted will double by theyear 2020. “I am seeing more and more patients with early signs of AMD,” said Dr. Kelly,”and nowhave a powerful tool to help me with a comprehensive risk mitigation plan for my patients who may beat risk.”Seventy-five to eighty percent of all AMD cases have been traced to genes inherited from familymembers “This means that family members of AMD patients need to be screened and monitored inhopes of preventing this disease. For those at risk supplementing with MacuHealth builds a healthyprotective layer of macular pigment in their eyes before signs and symptoms of AMD are likely toappear”, stated Dr. Kelly.
MacuHealth® prescribed as a “Macular Pigment Replacement Therapy”
Only MacuHealth is formulated with therapeutic levels of the three carotenoids found in the macula:lutein, zeaxanthin, and meso-zeaxanthin which are essential for rebuilding macular protective pigment.
Meso-zeaxanthin is the most important of the three as it is found exclusively in the center of themacula, the fovea, the area where the disease presents itself… affecting our central vision.Supplementing with meso-zeaxanthin is necessary because it’s quite difficult to get in our Westernizeddiet. It’s found in oysters, the skin of salmon and trout, and the shells of shrimp and turtle.
It can also be converted from Lutein in a process that requires a certain enzyme in the body to make thatconversion, an enzyme that not all of us have. Therefore we must consider all people over the age of50, who meet the risk categories, as candidates for the MacuHealth supplement in order to restoremacular pigment to healthy protective levels and provide the best possible defense against AgeRelated Macular Degeneration.
For further information about Retina scans and retinal health, please contact:
49 S. 2nd St.
Oxford, PA 19363
Phone: (610) 932-9356
Fax: (610) 932-3097